Hyperfractionated versus conventional radiotherapy followed by chemotherapy in standard-risk medulloblastoma: results from the randomized multicenter HIT-SIOP PNET 4 trial.
暂无分享,去创建一个
T. Björk-Eriksson | G. Gustafsson | D. Figarella-Branger | T. Pietsch | R. Kortmann | S. Rutkowski | M. Massimino | S. Clifford | J. Giralt | K. von Hoff | B. Lannering | F. Doz | V. Mosseri | C. Carrie | B. Pizer | A. Faldum | L. Gandola | M. Benesch | A. Navajas | R. Reddingius | M. Forni | F. Oldenburger | M. Warmuth-Metz | K. Robson | R. Taylor
[1] W. Hartmann,et al. Large cell/anaplastic medulloblastoma: Outcome according to myc status, histopathological, and clinical risk factors , 2010, Pediatric blood & cancer.
[2] B. Hinkes,et al. Long-term outcome and clinical prognostic factors in children with medulloblastoma treated in the prospective randomised multicentre trial HIT'91. , 2009, European journal of cancer.
[3] D. Figarella-Branger,et al. Online quality control, hyperfractionated radiotherapy alone and reduced boost volume for standard risk medulloblastoma: long-term results of MSFOP 98. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] T. Merchant,et al. Hearing loss after radiotherapy for pediatric brain tumors: effect of cochlear dose. , 2008, International journal of radiation oncology, biology, physics.
[5] B. Scheithauer,et al. The 2007 WHO Classification of Tumours of the Central Nervous System , 2007, Acta Neuropathologica.
[6] T. Merchant,et al. Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial. , 2006, The Lancet. Oncology.
[7] P. Burger,et al. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] K. Knight,et al. Ototoxicity in children receiving platinum chemotherapy: underestimating a commonly occurring toxicity that may influence academic and social development. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] D. Frappaz,et al. Standard-risk medulloblastoma treated by adjuvant chemotherapy followed by reduced-dose craniospinal radiation therapy: a French Society of Pediatric Oncology Study. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] J. Grill,et al. Conformal radiotherapy, reduced boost volume, hyperfractionated radiotherapy, and online quality control in standard-risk medulloblastoma without chemotherapy: results of the French M-SFOP 98 protocol. , 2003, International journal of radiation oncology, biology, physics.
[11] P. Burger,et al. Anaplasia and Grading in Medulloblastomas , 2003, Brain pathology.
[12] D. Ellison,et al. Morphophenotypic Variation Predicts Clinical Behavior in Childhood Non‐Desmoplastic Medulloblastomas , 2003, Journal of neuropathology and experimental neurology.
[13] D. Tait,et al. Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for nonmetastatic medulloblastoma: The International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 Study. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] R. Ellenbogen,et al. Concurrent chemotherapy and reduced-dose cranial spinal irradiation followed by conformal posterior fossa tumor bed boost for average-risk medulloblastoma: efficacy and patterns of failure. , 2002, International journal of radiation oncology, biology, physics.
[15] N. Willich,et al. Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT '91. , 2000, International journal of radiation oncology, biology, physics.
[16] L. Rorke,et al. Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group Study. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] L. Rorke,et al. Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] M. Prados,et al. Hyperfractionated craniospinal radiation therapy for primitive neuroectodermal tumors: results of a Phase II study. , 1999, International journal of radiation oncology, biology, physics.
[19] A. Nirenberg,et al. Thyroid dysfunction as a late effect in survivors of pediatric medulloblastoma/Primitive neuroectodermal tumors , 1997, Cancer.
[20] A. Nirenberg,et al. Hyperfractionated craniospinal radiotherapy and adjuvant chemotherapy for children with newly diagnosed medulloblastoma and other primitive neuroectodermal tumors. , 1996, International journal of radiation oncology, biology, physics.
[21] L. Rorke,et al. Effects of medulloblastoma resections on outcome in children: a report from the Children's Cancer Group. , 1996, Neurosurgery.
[22] J. Fowler. The linear-quadratic formula and progress in fractionated radiotherapy. , 1989, The British journal of radiology.
[23] D. Louis. WHO classification of tumours of the central nervous system , 2007 .
[24] A. Urgesi,et al. Thyroid dysfunction as a late effect in childhood medulloblastoma: a comparison of hyperfractionated versus conventionally fractionated craniospinal radiotherapy. , 2001, International journal of radiation oncology, biology, physics.
[25] L. Strauss,et al. Hyperfractionated craniospinal radiation in medulloblastoma. , 1996, Pediatric neurosurgery.
[26] C. R. Pinkerton,et al. Cisplatin ototoxicity in children: a practical grading system. , 1991, Medical and pediatric oncology.